The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The glutathione cycle shapes synaptic glutamate activity
Published version of a preprint
Abstract
Significance: Glutathione is a major antioxidant and redox regulator in cells. In addition to its essential roles in redox homeostasis, it functions as cofactors for a multitude of enzymes. We show here that the glutathione cycle molds the activity of synaptic glutamate, the major excitatory neurotransmitter in the central nervous system. Deficits in glutathione have been linked to multiple neurodegenerative and neuropsychiatric disorders. Accordingly, agents that restore glutathione-glutamate homeostasis may afford therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glutamate plays roles in cells including imparting antioxidant effects via synthesis of reduced glutathione (GSH).
“In addition to its role as an excitatory neurotransmitter, glutamate also plays other important roles in cells including imparting antioxidant effects via the synthesis of reduced glutathione (GSH) [118].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Self-citationMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267 · cited 1×
“S1), in which glutamate is added and liberated at discrete steps (4, 11).”
BackgroundKanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450 · cited 1×
“Glia serve as a major supplier of cysteine for neuronal glutathione synthesis, and 50-60% of glutamate neurotransmitter is derived from the glutamine-glutamate shuttle between neurons and glia, with substantially smaller amounts of glutamate transmitter derived from glycolysis (12-14).”
BackgroundAltered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202
das Neves Duarte, J. M., Kulak, A., Gholam-Razaee, M. M., Cuenod, M., Gruetter, R., & Do, K. Q. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.035 · Cited by 124
Kulak, A., Cuenod, M., & Do, K. Q. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.020 · Cited by 90
Glutathione is a physiologic reservoir of neuronal glutamate
Koga, M., Serritella, A. V., Messmer, M. M., Hayashi-Takagi, A., Hester, L. D., Snyder, S. H., Sawa, A., & Sedlak, T. W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.087 · Cited by 73
Self-citation
Flagged first, then by citations
Research works printed but not linked: 64
- 10.2174/092986709787549271 · DOI
- 10.1038/nrn2515 · DOI · Paper page
- 10.1196/annals.1418.005 · DOI · Paper page
- 10.1254/jphs.08R01CR · DOI
- 10.1007/978-0-387-30373-4_15 · DOI
- 10.1111/j.1749-6632.2002.tb04690.x · DOI
- 10.1146/annurev.pharmtox.45.120403.095857 · DOI
- 10.1515/BC.2009.033 · DOI
- 10.1523/JNEUROSCI.3885-07.2007 · DOI · Paper page
- 10.1016/0006-8993(79)90306-8 · DOI
- 10.1111/j.1471-4159.1983.tb04785.x · DOI
- 10.1523/JNEUROSCI.1198-07.2007 · DOI
- 10.1523/JNEUROSCI.2601-12.2012 · DOI
- 10.1038/nprot.2006.378 · DOI
- 10.1023/A:1027310328310 · DOI
- 10.1016/S0076-6879(05)01027-X · DOI
- 10.1523/JNEUROSCI.19-02-00562.1999 · DOI · Paper page
- 10.1016/j.freeradbiomed.2015.04.036 · DOI · Paper page
- 10.1073/pnas.140152797 · DOI
- 10.1172/JCI103058 · DOI
- 10.1523/JNEUROSCI.4241-05.2006 · DOI
- 10.1073/pnas.252626999 · DOI
- 10.1016/S0896-6273(02)00692-X · DOI
- 10.1523/JNEUROSCI.4415-06.2007 · DOI
- 10.1523/JNEUROSCI.23-09-03633.2003 · DOI
- 10.1111/j.1469-7793.2000.t01-1-00195.x · DOI
- 10.1007/s10571-011-9748-4 · DOI
- 10.1515/BC.2006.173 · DOI
- 10.1002/jnr.490300316 · DOI
- 10.1523/JNEUROSCI.15-02-01384.1995 · DOI
- H Amal, , Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Mol Psychiatry, July 9, 2018).
- 10.1016/j.molmed.2009.06.007 · DOI · Paper page
- 10.1016/j.cbpa.2010.10.012 · DOI
- 10.1016/S0896-6273(00)80146-4 · DOI
- 10.1016/j.neures.2006.04.016 · DOI
- M Liguz-Lecznar, J Skangiel-Kramska, Vesicular glutamate transporters (VGLUTs): The three musketeers of glutamatergic system. Acta Neurobiol Exp (Warsz) 67, 207–218 (2007). · DOI
- 10.1016/S0896-6273(01)00176-3 · DOI
- 10.1016/j.neuron.2010.04.028 · DOI · Paper page
- 10.1523/JNEUROSCI.15-11-07168.1995 · DOI
- 10.1016/0006-8993(87)90712-8 · DOI
- 10.1523/JNEUROSCI.16-01-00019.1996 · DOI
- 10.1176/appi.ajp.157.7.1141 · DOI
- 10.1001/archpsyc.1995.03950220039008 · DOI
- 10.1016/j.brainresbull.2010.04.006 · DOI
- 10.1016/j.schres.2015.06.022 · DOI
- 10.1038/mp.2015.141 · DOI
- 10.1016/j.conb.2009.05.001 · DOI · Paper page
- 10.1046/j.1460-9568.2000.00229.x · DOI · Paper page
- 10.1371/journal.pone.0001944 · DOI
- 10.1038/tp.2017.178 · DOI
- 10.1016/S0009-2797(97)00155-5 · DOI
- 10.1007/s00439-005-1255-6 · DOI
- 10.1038/nm.2615 · DOI
- 10.1007/s11064-013-1199-5 · DOI
- M Anna, , 7 Tesla proton magnetic resonance spectroscopy in first episode psychosis. JAMA Psychiatry, January 9, 2019).
- 10.1111/j.1749-6632.2011.06092.x · DOI
- 10.1016/j.neulet.2005.09.065 · DOI
- 10.1159/000487639 · DOI
- 10.1073/pnas.1416940111 · DOI · Paper page
- 10.1016/j.jneumeth.2008.02.019 · DOI
- 10.1111/j.1472-8206.1990.tb00485.x · DOI
- E Sinforiani, , Reversibility of cognitive disorders among chronic alcoholics in phases of withdrawal. Effect of arginine pyroglutamate. Minerva Psichiatr 26, 339–346 (1985).
- 10.1007/s00213-009-1648-7 · DOI
- 10.1038/nn.2487 · DOI · Paper page
Cited by
Sorted by citations
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
Mendiola, A. S., Ryu, J. K., Bardehle, S., Meyer-Franke, A., Ang, K. K.-H., Wilson, C., Baeten, K. M., Hanspers, K., Merlini, M., Thomas, S., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0654-0 · Cited by 199
Glutathione Metabolism of the Brain—The Role of Astrocytes
Dringen, R., & Arend, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70073 · Cited by 46
Jones, E., Adams, H., Chen, K.-E., Maroof, F., Ibbotson, T. M., Nakamura, Y., Banks, P. J., Healy, M. D., Lewis, P. A., Heesom, K. J., et al. (2026) · doi:10.64898/2026.05.14.724903
Metadata
- Authors
- Sedlak, T. W., Paul, B. D., Parker, G. M., Hester, L. D., Snowman, A. M., Taniguchi, Y., Kamiya, A., Snyder, S. H., & Sawa, A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-01-28
- Volume
- 116
- Issue
- 7
- Pages
- 2701-2706
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 147
- References
- 10
- Language
- en
- Funders
- HHS | NIH | National Institute of Neurological Disorders and Stroke (1K08NS057824)
- National Alliance for Research on Schizophrenia and Depression (Young Investigator)
- HHS | NIH | National Institute of Mental Health (MH-092443, MH-094268, MH 084018, MH-105660)
- HHS | U.S. Public Health Service (MH18501)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review